Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Zhaoke Ophthalmology Ltd. ( (HK:6622) ) has shared an announcement.
Zhaoke Ophthalmology Ltd. held its Annual General Meeting on May 16, 2025, where all proposed resolutions were passed by the shareholders. Key resolutions included granting mandates to directors for share repurchase and issuance, re-electing directors, and re-appointing KPMG as auditors. The successful passing of these resolutions reflects shareholder confidence and supports the company’s strategic and operational plans.
More about Zhaoke Ophthalmology Ltd.
Zhaoke Ophthalmology Ltd. is a company incorporated in the British Virgin Islands and continued in the Cayman Islands, focusing on ophthalmic products and services. It is listed on the Hong Kong Stock Exchange under the stock code 6622.
Average Trading Volume: 2,463,115
Technical Sentiment Signal: Buy
Current Market Cap: HK$972.1M
For an in-depth examination of 6622 stock, go to TipRanks’ Stock Analysis page.

